Long Noncoding RNA TUG1 Promotes Autophagy-Associated Paclitaxel Resistance by Sponging miR-29b-3p in Ovarian Cancer Cells

PURPOSE: Paclitaxel (PTX) is a first-line chemotherapeutic agent for treating ovarian cancer. However, PTX resistance has become a major obstacle in ovarian cancer therapy. The underlying mechanism associated with PTX resistance is still unclear. PATIENTS AND METHODS: We used qPCR to detect taurine...

Descripción completa

Detalles Bibliográficos
Autores principales: Gu, Lize, Li, Qing, Liu, Hao, Lu, Xun, Zhu, Mingchen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065918/
https://www.ncbi.nlm.nih.gov/pubmed/32189969
http://dx.doi.org/10.2147/OTT.S240434

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7065918/
https://www.ncbi.nlm.nih.gov/pubmed/32189969
http://dx.doi.org/10.2147/OTT.S240434

Ejemplares similares